NCT07119398
Oxytocin/Foley vs. Oxytocin for Induction in Patients With PPROM
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Stopped Trial terminated Sponsor's reason: poor accrual Show 6 more changesShow less
- Final enrollment: 2 participants, 3% of the 80 planned
- Eligibility criteria expanded, about 14 words
- Primary completion date changed from estimate of Jul 30, 2026 to Nov 16, 2026
- Secondary endpoints revised (19)
- Site details revised
- Publications: details revised at 7 of 7 entries
- Study First Submitted
- Stopped: terminated, suspended or withdrawn
Endpoints
Primary
Vaginal Delivery within 12 Hours
Timeframe: 12 hours
Secondary (19)
Vaginal Delivery Rate
Intraamniotic Infection
Operative vaginal delivery
Cesarean delivery
Estimated and quantitative blood loss
Show 14 moreShow less
Blood transfusion
Maternal morbidity and adverse maternal outcomes
Antepartum, intrapartum, or neonatal death
Suspected and confirmed neonatal sepsis
Birth weight
Hypoglycemia (glucose < 35 mg/dl) requiring IV glucose therapy
Intubation, continuous positive airway pressure (CPAP) or high-flow nasal cannula (HFNC) for ventilation or cardiopulmonary resuscitation within first 72 hours
Neonatal encephalopathy
Seizures
Shoulder dystocia
Birth trauma
Intracranial hemorrhage
Hyperbilirubinemia requiring phototherapy or exchange transfusion
NICU admission
Arms and interventions
Oxytocin plus FoleyExperimental
• Induction of labor with intravenous oxytocin and a transcervical Foley catheter
Oxytocin OnlyActive comparator
• Induction of labor with intravenous oxytocin
Combination products: Oxytocin plus Foley Catheter
Drugs: Oxytocin
Sites
1 site in 1 country
- Sentara Norfolk General HospitalNorfolk, Virginia, United States